Cargando…
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
Currently, there is no effective vaccine to halt HIV transmission. However, pre-exposure prophylaxis (PrEP) with the drug combination Truvada can substantially decrease HIV transmission in individuals at risk. Despite its benefits, Truvada-based PrEP is expensive and needs to be taken once-daily, wh...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370240/ https://www.ncbi.nlm.nih.gov/pubmed/30699105 http://dx.doi.org/10.1371/journal.pcbi.1006740 |